Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial

Anthony R Mato, Lindsey E Roeker, John N Allan, John M Pagel, Danielle M Brander, Brian T Hill, Bruce D Cheson, Richard R Furman, Nicole Lamanna, Constantine S Tam, Sasanka Handunnetti, Ryan Jacobs, Frederick Lansigan, Erica Bhavsar, Paul M Barr, Mazyar Shadman, Alan P Skarbnik, Andre Goy, Douglas F Beach, Jakub Svoboda Show all